277 related articles for article (PubMed ID: 2040694)
1. The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia.
Ahuja H; Bar-Eli M; Arlin Z; Advani S; Allen SL; Goldman J; Snyder D; Foti A; Cline M
J Clin Invest; 1991 Jun; 87(6):2042-7. PubMed ID: 2040694
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms in the evolution of chronic myelocytic leukemia.
Cline MJ; Jat PS; Foti A
Leuk Lymphoma; 1992 Jul; 7(4):283-7. PubMed ID: 1493427
[TBL] [Abstract][Full Text] [Related]
3. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
Okabe M
Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066
[TBL] [Abstract][Full Text] [Related]
4. No correlation between locations of bcr breakpoints and clinical states in Ph1-positive CML patients.
Ogawa H; Sugiyama H; Soma T; Masaoka T; Kishimoto S
Leukemia; 1989 Jul; 3(7):492-6. PubMed ID: 2733454
[TBL] [Abstract][Full Text] [Related]
5. [Rearrangement and expression of bcr-abl genes in CML and ALL].
Kunieda Y; Okabe M
Rinsho Ketsueki; 1991 Jun; 32(6):623-8. PubMed ID: 1890738
[TBL] [Abstract][Full Text] [Related]
6. Absence of N-ras mutations in myeloid and lymphoid blast crisis of chronic myeloid leukemia.
Watzinger F; Gaiger A; Karlic H; Becher R; Pillwein K; Lion T
Cancer Res; 1994 Jul; 54(14):3934-8. PubMed ID: 8033117
[TBL] [Abstract][Full Text] [Related]
7. Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia.
Guo JQ; Hirsch-Ginsberg CF; Xian YM; Stass SA; Champlin RE; Giralt SA; McCredie KB; Campbell ML; Arlinghaus RB
Hematol Pathol; 1993; 7(2):91-106. PubMed ID: 8340287
[TBL] [Abstract][Full Text] [Related]
8. Correlation between molecular and clinical events in the evolution of chronic myelocytic leukemia to blast crisis.
Foti A; Ahuja HG; Allen SL; Koduru P; Schuster MW; Schulman P; Bar-Eli M; Cline MJ
Blood; 1991 Jun; 77(11):2441-4. PubMed ID: 2039825
[TBL] [Abstract][Full Text] [Related]
9. High frequency of RAS oncogene mutation in chronic myeloid leukemia patients with myeloblastoma.
Tanaka K; Takauchi K; Takechi M; Kyo T; Dohy H; Kamada N
Leuk Lymphoma; 1994 Apr; 13(3-4):317-22. PubMed ID: 8049652
[TBL] [Abstract][Full Text] [Related]
10. Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia--potential clinical significance.
Inokuchi K; Yamaguchi H; Tarusawa M; Futaki M; Hanawa H; Tanosaki S; Dan K
Leukemia; 2002 Feb; 16(2):170-7. PubMed ID: 11840282
[TBL] [Abstract][Full Text] [Related]
11. Frequent p53 gene mutations in blast crisis of chronic myelogenous leukemia, especially in myeloid crisis harboring loss of a chromosome 17p.
Nakai H; Misawa S; Toguchida J; Yandell DW; Ishizaki K
Cancer Res; 1992 Dec; 52(23):6588-93. PubMed ID: 1423304
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of a CML patient with a long duration of chronic phase before and after lymphoid blast crisis.
Price CM; Foadi MD; Morgan GJ; Wiedemann LM
Leukemia; 1990 Jun; 4(6):455-7. PubMed ID: 2359347
[TBL] [Abstract][Full Text] [Related]
13. Mutations of the ras protooncogenes in chronic myelogenous leukemia: a high frequency of ras mutations in bcr/abl rearrangement-negative chronic myelogenous leukemia.
Cogswell PC; Morgan R; Dunn M; Neubauer A; Nelson P; Poland-Johnston NK; Sandberg AA; Liu E
Blood; 1989 Dec; 74(8):2629-33. PubMed ID: 2684296
[TBL] [Abstract][Full Text] [Related]
14. Genetic alterations in the p53 gene in the blast crisis of chronic myelogenous leukemia: analysis by polymerase chain reaction based techniques.
Neubauer A; He M; Schmidt CA; Huhn D; Liu ET
Leukemia; 1993 Apr; 7(4):593-600. PubMed ID: 8464238
[TBL] [Abstract][Full Text] [Related]
15. Rearrangement and expression of p53 in the chronic phase and blast crisis of chronic myelogenous leukemia.
Mashal R; Shtalrid M; Talpaz M; Kantarjian H; Smith L; Beran M; Cork A; Trujillo J; Gutterman J; Deisseroth A
Blood; 1990 Jan; 75(1):180-9. PubMed ID: 1967214
[TBL] [Abstract][Full Text] [Related]
16. Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia.
Ahuja H; Bar-Eli M; Advani SH; Benchimol S; Cline MJ
Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6783-7. PubMed ID: 2771957
[TBL] [Abstract][Full Text] [Related]
17. [Ph1-positive leukemia: cytogenetic outline and prognosis].
Misawa S
Nihon Rinsho; 1992 Jun; 50(6):1274-80. PubMed ID: 1518145
[TBL] [Abstract][Full Text] [Related]
18. [The cellular and molecular-biological studies on Philadelphia chromosome-positive acute lymphocytic leukemia].
Kunieda Y
Hokkaido Igaku Zasshi; 1993 May; 68(3):337-49. PubMed ID: 8319933
[TBL] [Abstract][Full Text] [Related]
19. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
Steinberg M
Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
[TBL] [Abstract][Full Text] [Related]
20. Rearrangements of immunoglobulin- and BCR-genes in chronic myeloid leukemia.
Tesch H; Fonatsch C; Diehl V
In Vivo; 1991; 5(3):233-8. PubMed ID: 1893079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
